Clinical Trial Update: OMT-111 for Terminal Stage Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update for OMT-111 in terminal-stage solid tumors including breast and pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• OMT-111

Snippet

Sponsor: MetiMedi Pharmaceuticals | Conditions: Breast Cancer, Pancreatic Cancer | Phase 2 | Status: UNKNOWN